eClinical Solutions Market

eClinical Solutions Market by Clinical Trial Phases, Product (CTMS, eCOA, Analytics, RTMS, eTMF, Safety, CDMS, EDC), Delivery Mode (On-Demand, On-premise, Cloud-based), End User (CROs, Hospitals, Pharma/Biopharma Companies) - Global Forecast to 2022

Report Code: HIT 2208 Apr, 2017, by marketsandmarkets.com
COVID-19

Get in-depth analysis of how COVID-19 is impacting the eClinical Solutions Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the eClinical Solutions Market

Request Now
Updated date -

The global eClinical solutions market is estimated to reach 7.61 billion by 2022, at a CAGR of 12.4% within the forecast period of 2017 to 2022. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and increasing R&D expenditure by pharma-biotech companies with augmented IT budgets for drug development are some of the major driving factors for the global eClinical solutions market.

eClinical Solutions Market

The web-based delivery mode segment commanded the largest share of the global eClinical solutions market.

On the basis of delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premise), and cloud-based (SaaS) solutions. In 2016, the web-hosted (on-demand) segment commanded the largest share of the global eClinical solutions market. A number of factors such as easy user access, reductions in cost, and faster retrieval of data are responsible for its prominent market share. The cloud-based delivery mode segment is estimated to register the highest growth rate during the forecast period. The ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee offered by cloud-based models are expected to drive the demand for these solutions.

The pharmaceutical and biopharmaceutical companies segment to grow the fastest in the global eClinical solutions market by end user.

On the basis of end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical. device manufacturers, hospitals, and academic research institutions. The pharmaceutical and biopharmaceutical companies segment to grow with highest CAGR in the eClinical solutions market in 2016. Pharmaceutical and biopharmaceutical companies primarily utilize software solutions during clinical trials in order to receive regulatory approvals for newly developed drugs. Application of eClinical solutions increases the efficiency of clinical trials and results in reductions in the overall cost and time involved in drug development. These benefits have resulted in an increase in the adoption of software technologies by pharmaceutical and biopharmaceutical companies for drug development and hence commanded the largest share in the market.

North America will dominate the eClinical solutions market during the forecast period

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the global eClinical solutions market; the market in Asia-Pacific is expected to grow at the highest CAGR. This is primarily attributed to the increasing outsourcing of clinical trials by large pharmaceutical and biopharmaceutical organizations to developing Asia-Pacific countries, growth in government funding to support clinical research, presence of less stringent regulatory guidelines compared to developed nations to conduct clinical trials, presence of a large patient base, and faster patient recruitment for clinical trials in the region.

eClinical Solutions Market

Market Dynamics

A number of software platforms are used in the eClinical solutions industry that helps end users to automate and accelerate clinical research and related developmental processes. They help in efficient and accurate research planning, preparation, and study performance, as well as in accurate reporting & documentation of clinical trials data. Moreover, these software products offer enhanced quality & accuracy of clinical processes and related data analysis in addition to reduced project time and overall costs. This market is primarily driven by the increasing operational costs, and growing customer base for eClinical solutions.

eClinical Solutions Market

Report Scope

Global eClinical solutions Market, by Product

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Clinical Analytics Platform
  • Randomization and Trial Supply Management (RTMS)
  • Clinical Data Integration Platform
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trail Master Files (eTMF)
  • Regulatory Information Management Solutions (RIMS)
  • Others (Coding Systems, Institutional Review Board (IRB) Systems, and Core Lab Integration Solutions)

Global eClinical solutions Market, by Delivery Mode

  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based (SaaS)

Global eClinical solutions Market, by Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global eClinical solutions Market, by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutions

Global eClinical solutions Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa

Key Market Players

Oracle Corporation (US), Medidata Solutions, Inc. (US), PAREXEL International Corporation (US), and BioClinica, Inc. (US) among others are the major players operating in the eClinical solutions market. CRF Health (US), DATATRAK International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US) are some other key players operating in this market.

Partnerships, agreements, and collaborations are key growth strategies adopted by major players to enhance their positions in this market. Strategies such as product launches, enhancements, and deployments; mergers, and acquisitions; and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global eClinical solutions market.

Recent Developments

  • In September 2016, Medidata (US) partnered with SHYFT Analytics (US) for its healthcare data analytics solutions. Through this partnership, Medidata is able to provide real world evidence (RWE) data from electronic medical records (EMRs) and health claims to its customers.
  • In April 2016, PAREXEL (US0 entered into an alliance with EMC Corporation (US) to provide end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution. Under this alliance, PAREXEL’s LIQUENT InSight Regulatory Information Management platform integrates with EMC’s Documentum (a life sciences software solution suite) to offer a complete solution for regulatory process management.
  • In October 2016, Cinven (UK based private equity firm) acquired Bioclinica (US) from JLL Partners for an undisclosed value. Following the acquisition, BioClinica receives funds from Cinven. This acquisition helped BioClinica to expand its footprints in the global eClinical solutions market.

Key Questions Addressed in This Report

  • What are the various types of eclinical solution products offered by the top market players for in established & emerging regions?
  • Who are the major players offering EDC and CDMS products in major geographies?
  • What revenue impact will electronical clinical outcome assessment solutions have in the market during the forecast period?
  • What is the adoption pattern for the eclinical solution products by various end users across the globe?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table Of Contents

1 Introduction
    1.1 Objectives of The Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered For The Study
    1.4 Currency Used for The Study
    1.5 Stakeholders

2 Research Methodology
    2.1 Primary Data
    2.2 Secondary Data
    2.3 Market Size Estimation Methodology
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Market Dynamics
           5.2.1 Major Market Drivers
                    5.2.1.1 Increasing Operational Costs and Regulatory Requirements associated With Clinical Research Studies
                    5.2.1.2 Growing Adoption of Novel Software Solutions In Clinical Research
                    5.2.1.3 Rising Government Funding & Grants to Support Clinical Trials
                    5.2.1.4 Growing Adoption of Eclinical Solutions for Improved Data Standardization
                    5.2.1.5 Increasing R&D Expenditure By Pharma-Biotech Companies With Augmented It Expenditure Allocations for Drug Development Pipeline
                    5.2.1.6 Growing Customer Base for Eclinical Solutions
           5.2.2 Major Market Restraints
                    5.2.2.1 High Implementation Costs associated With Eclinical Solutions
                    5.2.2.2 Dearth of Skilled Professionals for Operating Eclinical Solutions
                    5.2.2.3 Limited Awareness Among Researchers Related to Advantages of Eclinical Solutions
           5.2.3 Key Growth Opportunities
                    5.2.3.1 Increasing Clinical Research Activities In Emerging asian Countries
                    5.2.3.2 Increased Outsourcing of Clinical Trial Processes By Industrial Researchers to Cros
                    5.2.3.3 Rising Number of Clinical Trials, Especially Across Emerging Countries
                    5.2.3.4 Shift From Manual Data Interpretation to Real-Time Data Analysis During Clinical Studies
           5.2.4 Major Market Challenges
                    5.2.4.1 Limited Adoption of Eclinical Solutions In Developing Nations
                    5.2.4.2 Software Reliability
                    5.2.4.3 Patient Privacy

6 Global Eclinical Solutions Market, By Product (USD Million; 2015-2022)
    6.1 Introduction
    6.2 Electronic Data Capture and Clinical Data Management Systems
    6.3 Clinical Trial Management Systems
    6.4 Clinical Analytics Platforms
    6.5 Randomization and Trial Supply Management
    6.6 Clinical Data Integration Platforms
    6.7 Electronic Clinical Outcome assessment Solutions
    6.8 Safety Solutions
    6.9 Electronic Trial Master File Systems
    6.1 Regulatory Information Management Solutions
    6.11 Other Eclinical Solutions

7 Eclinical Solutions Market, By Delivery Mode (USD Million; 2015-2022)
    7.1 Introduction
    7.2 Web-Hosted (On-Demand) Solutions
    7.3 Licensed Enterprise (On-Premise) Solutions
    7.4 Cloud-Based (Saas) Solutions

8 Global Eclinical Solutions Market, By Clinical Trial Phase (USD Million; 2015-2022)
    8.1 Introduction
    8.2 Phase I Clinical Trials
    8.3 Phase Ii Clinical Trials
    8.4 Phase Iii Clinical Trials
    8.5 Phase Iv Clinical Trials

9 Eclinical Solutions Market, By End User (USD Million; 2015-2022)
    9.1 Introduction
    9.2 Pharmaceutical and Biopharmaceutical Companies
    9.3 Contract Research Organizations
    9.4 Consulting Service Companies
    9.5 Medical Device Manufacturers
    9.6 Hospitals
    9.7 Academic Research Institutes

10 Eclinical Solutions Market, By Region (USD Million; 2015-2022) 
     10.1 Introduction
     10.2 North America
             10.2.1 Us.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany.
             10.3.2 Uk.
             10.3.3 France.
             10.3.4 Italy.
             10.3.5 Spain.
             10.3.6 Roe.
     10.4 Asia-Pacific
             10.4.1 Japan.
             10.4.2 China.
             10.4.3 India.
             10.4.4 Roapac.
     10.5 Latin America
             10.5.1 Brazil.
             10.5.2 Mexico.
             10.5.3 Rola.
     10.6 Middle East & Africa

11 Competitive Landscape
     11.1 Overview
     11.2 Eclinical Solutions Market Share Analysis, By top 3 Global Players (In Terms of %Revenue Share as of 2016)
     11.3 Competitive Scenerio (2013-2017)
             11.3.1 New Product Launches
             11.3.2 Partnerships and Collaborations
             11.3.3 Mergers and Acquisitions
             11.3.4 Expansions
     11.4  Competitive Leadership Mapping (For 25 Major Market Players)
             11.4.1 Vendor Inclusion Criteria
                        11.4.1.1 Visionary Leaders
                        11.4.1.2 Innovators
                        11.4.1.3 Dynamic Differentiators
                        11.4.1.4 Emerging Companies
     11.5 Competitive Leadership Mapping (For Start-Ups/Emerging Companies)
             11.5.1 Vendor Inclusion Criteria
                        11.5.1.1 Progressive Companies
                        11.5.1.2 Starting/Emerging Blocks
                        11.5.1.3 Responsive Companies
                        11.5.1.4 Dynamic Companies

12 Company Profiles***
(Business Overview, Products offered, Indsutry Sepcific Developments for 2013-2017)****
     12.1 Introduction
     12.2 Oracle Corporation
     12.3 Medidata Solutions, Inc.
     12.4 Parexel International Corporation
     12.5 Bioclinica, Inc. (A Subsidiary of Cinven)
     12.6 Datatrak International, Inc.
     12.7 Crf Health
     12.8 Ert Clinical
     12.9 Merge Healthcare Incorporated
     12.1 Omnicomm Systems, Inc.
     12.11 Maxisit Inc.
     12.12 Bio-Optronics, Inc.
     12.13 Eclinical Solutions, Llc.

13 Appendix
     13.1 Discussion Guide*
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing Rt: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details

* Market Segmentation Might Change Slightly Based on Insights Gathered During The Course of The Actual Research Study.
**Similar Regional and Country Level Market Value Data Shall Be Covered for All Segments and Sub-Segments of Chapter 6,7,8 and 9.
***The top 13 Companies In The Global E-Clinical Solutions System Market Shall Be Profiled; The List Shall Be Decided Based on Insights Gathered During The Course of The Actual Research Study.
****Details on Financial Overview, Product Portfolio, and Market-Specific Developments Might Not Be Captured In Case of Unlisted/Privately-Held Companies; Those Do Not Provide Above Information In Public Domain.

List of Tables ( 156 Tables)

Table 1 U.S.: Indicative List of Life Science Startups Launched Between 2011 & 2015
Table 2 Global Eclinical Solutions Market Size, By Product,2015–2022 (USD Million)
Table 3 Global Electronic Data Capture and Clinical Data Management Systems Market Size, By Region, 2015–2022 (USD Million)
Table 4 North America: Electronic Data Capture and Clinical Data Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 4 Europe: Electronic Data Capture and Clinical Data Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 5 Asia Pacific: Electronic Data Capture and Clinical Data Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 6 Latin America: Electronic Data Capture and Clinical Data Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 7 Middle East & Africa: Electronic Data Capture and Clinical Data Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 8 Global Clinical Trial Management Systems Market Size, By Region, 2015–2022 (USD Million)
Table 9 North America: Clinical Trial Management Systems Market Size,By Country, 2015–2022 (USD Million)
Table 10 Europe: Clinical Trial Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 11 Asia Pacific: Clinical Trial Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 12 Latin America: Clinical Trial Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 13 Middle East & Africa: Clinical Trial Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 14 Global Clinical Analytics Platforms Market Size, By Region,2015–2022 (USD Million)
Table 15 North America: Clinical Analytics Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 16 Europe: Electronic Clinical Analytics Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 17 Asia Pacific: Clinical Analytics Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 18 Latin America: Clinical Analytics Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 19 Middle East & Africa: Clinical Analytics Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 20 Global Randomization and Trial Supply Management Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 21 North America: Randomization and Trial Supply Management Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 22 Europe: Domization and Trial Supply Management Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 23 Asia Pacific: Domization and Trial Supply Management Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 24 Latin America: Domization and Trial Supply Management Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 25 Middle East & Africa: Domization and Trial Supply Management Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 26 Global Clinical Data Integration Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 27 North America: Clinical Data Integration Platforms Market Size,By Country, 2015–2022 (USD Million)
Table 28 Europe: Clinical Data Integration Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 29 Asia Pacific: Clinical Data Integration Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 30 Latin America: Clinical Data Integration Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 31 Middle East & Africa: Clinical Data Integration Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 32 Global Electronic Clinical Outcome Assessment Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 33 North America: Electronic Clinical Outcome assessment Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 34 Europe: Electronic Clinical Outcome assessment Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 35 Asia Pacific: Electronic Clinical Outcome assessment Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 36 Latin America: Electronic Clinical Outcome assessment Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 37 Middle East & Africa: Electronic Clinical Outcome assessment Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 38 Global Safety Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 39 North America: Safety Solutions Market Size, By Country,2015–2022 (USD Million)
Table 40 Europe: Safety Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 41 Asia Pacific: Safety Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 42 Latin America: Safety Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 43 Middle East & Africa: Safety Solutions Systems Market Size, By Country, 2015–2022 (USD Million)
Table 44 Global Electronic Trial Master File Systems Market Size, By Region, 2015–2022 (USD Million)
Table 45 North America: Electronic Trial Master File Market Size, By Country, 2015–2022 (USD Million)
Table 46 Europe: Electronic Trial Master File Market Size, By Country, 2015–2022 (USD Million)
Table 47 Asia Pacific: Electronic Trial Master File Market Size, By Country, 2015–2022 (USD Million)
Table 48 Latin America: Electronic Trial Master File Market Size, By Country, 2015–2022 (USD Million)
Table 49 Middle East & Africa: Electronic Trial Master File Market Size, By Country, 2015–2022 (USD Million)
Table 50 Global Regulatory Information Management Solutions (Rims) Market Size, By Region, 2015–2022 (USD Million)
Table 51 North America: Global Regulatory Information Management Solutions (Rims) Market Size ,By Country, 2015–2022 (USD Million)
Table 52 Europe: Regulatory Information Management Solutions (Rims) Market Size, By Country, 2015–2022 (USD Million)
Table 53 Asia Pacific: Regulatory Information Management Solutions (Rims) Market Size, By Country, 2015–2022 (USD Million)
Table 54 Latin America: Regulatory Information Management Solutions (Rims) Market Size, By Country, 2015–2022 (USD Million)
Table 55 Middle East & Africa: Regulatory Information Management Solutions (Rims) Market Size, By Country, 2015–2022 (USD Million)
Table 56 Global Other Eclinical Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 57 North America: Other Eclinical Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 58 Europe: Other Eclinical Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 59 Asia Pacific: Other Eclinical Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 60 Latin America: Other Eclinical Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 61 Middle East & Africa: Other Eclinical Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 62 Global Eclinical Solutions Market Size, By Mode of Delivery,2015–2022 (USD Million)
Table 63 Web-Hosted Eclinical Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 64 Licensed Enterprise Eclinical Solutions Market Size, By Region,2015–2022 (USD Million)
Table 65 Cloud-Based Eclinical Solutions Market Size, By Region,2015–2022 (USD Million)
Table 66 Global Eclinical Solutions Market Size, By Clinical Trial Phase,2015–2022 (USD Million) 112
Table 67 Eclinical Solutions Market Size for Phase I Clinical Trials, By Region, 2015–2022 (USD Million)
Table 68 North America: Eclinical Solutions Market Size for Phase I Clinical Trials, By Country, 2015–2022 (USD Million)
Table 69 Europe: Eclinical Solutions Market Size for Phase I Clinical Trials, By Country, 2015–2022 (USD Million)
Table 70 Asia Pacific: Eclinical Solutions Market Size for Phase I Clinical Trials, By Country, 2015–2022 (USD Million)
Table 71 Latin America: Eclinical Solutions Market Size for Phase I Clinical Trials, By Country, 2015–2022 (USD Million)
Table 72 Middle East & Africa: Eclinical Solutions Market Size for Phase I Clinical Trials, By Country, 2015–2022 (USD Million)
Table 73 Eclinical Solutions Market Size for Phase Ii Clinical Trials, By Region, 2015–2022 (USD Million)
Table 74 North America: Eclinical Solutions Market Size for Phase Ii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 75 Europe: Eclinical Solutions Market Size for Phase Ii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 76 Asia Pacific: Eclinical Solutions Market Size for Phase Ii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 77 Latin America: Eclinical Solutions Market Size for Phase Ii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 78 Middle East & Africa: Eclinical Solutions Market Size for Phase Ii Clinical Trials, By Country, By Country, 2015–2022 (USD Million)
Table 79 Eclinical Solutions Market Size for Phase Iii Clinical Trials, By Region, 2015–2022 (USD Million)
Table 80 North America: Eclinical Solutions Market Size for Phase Iii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 81 Europe: Eclinical Solutions Market Size for Phase Iii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 82 Asia Pacific: Eclinical Solutions Market Size for Phase Iii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 83 Latin America: Eclinical Solutions Market Size for Phase Iii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 84 Middle East & Africa: Eclinical Solutions Market Size for Phase Iii Clinical Trials, By Country, 2015–2022 (USD Million)
Table 85 Eclinical Solutions Market Size for Phase Iv Clinical Trials, By Region, 2015–2022 (USD Million)
Table 86 North America: Eclinical Solutions Market Size for Phase Iv Clinical Trials, By Country, 2015–2022 (USD Million)
Table 87 Europe: Eclinical Solutions Market Size for Phase Iv Clinical Trials, By Country, 2015–2022 (USD Million)
Table 88 Asia Pacific: Eclinical Solutions Market Size for Phase Iv Clinical Trials, By Country, 2015–2022 (USD Million)
Table 89 Latin America: Eclinical Solutions Market Size for Phase Iv Clinical Trials, By Country, 2015–2022 (USD Million)
Table 90 Middle East & Africa: Eclinical Solutions Market Size for Phase Iv Clinical Trials, By Country, 2015–2022 (USD Million)
Table 91 Global Eclinical Solutions Market Size, By End User, 2015–2022 (USD Million)
Table 92 Eclinical Solutions Market Size for Pharmaceutical and Biopharmaceutical Companies, By Region, 2015–2022 (USD Million)
Table 93 Key Strategic Alliances Between Cros and Pharma Companies(2011–2015)
Table 94 Eclinical Solutions Market Size for Cros, By Region, 2015–2022 (USD Million)
Table 95 Eclinical Solutions Market Size for Consulting Service Companies,By Region, 2015–2022 (USD Million)
Table 96 Eclinical Solutions Market Size for Medical Device Manufacturers,By Region, 2015–2022 (USD Million)
Table 97 Eclinical Solutions Market Size for Hospitals, By Region, 2015–2022 (USD Million)
Table 98 Eclinical Solutions Market Size for Academic Research Institutes,By Region, 2015–2022 (USD Million)
Table 99 Global Eclinical Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 100 North America: Eclinical Solutions Market Size, By Country,2015-2022 (USD Million)
Table 101 North America: Eclinical Solutions Market Size, By Product,2015-2022 (USD Million)
Table 102 North America: Eclinical Solutions Market Size, By Delivery Mode, 2015-2022 (USD Million)
Table 103 North America: Eclinical Solutions Market Size, By Clinical Trial Phase, 2015-2022 (USD Million)
Table 104 North America: Eclinical Solutions Market Size, By End User,2015-2022 (USD Million)
Table 105 Us: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 106 Us: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 107 Canada: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 108 Canada: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 109 Ema-Approved Biosimilars
Table 110 Europe: Eclinical Solutions Market Size, By Product, 2015–2022 (USD Million)
Table 111 Europe: Eclinical Solutions Market Size, By Delivery Mode, 2015–2022 (USD Million)
Table 112 Europe: Eclinical Solutions Market Size, By Clinical Trial Phase, 2015–2022 (USD Million)
Table 113 Europe: Eclinical Solutions Market Size, By End User, 2015–2022 (USD Million)
Table 114 Germany: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 115 Germany: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 116 Uk: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 117 Uk: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 118 France: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 119 France: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 120 Italy: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 121 Italy: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 122 Spain: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 123 Spain: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 124 Roe: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 125 Roe: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 126 Asia-Pacific: Eclinical Solutions Market Size, By Product, 2015–2022 (USD Million)
Table 127 Asia-Pacific: Eclinical Solutions Market Size, By Delivery Mode,2015–2022 (USD Million)
Table 128 Asia-Pacific: Eclinical Solutions Market Size, By Clinical Trial Phase, 2015–2022 (USD Million)
Table 129 Asia-Pacific: Eclinical Solutions Market Size, By End User,2015–2022 (USD Million)
Table 130 Japan: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 131 Japan: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 132 China: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 133 China: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 134 India: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 135 India: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 136 Roapac: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 137 Roapac: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 138 Latin America: Eclinical Solutions Market Size, By Product,2015–2022 (USD Million)
Table 139 Latin America: Eclinical Solutions Market Size, By Delivery Mode,2015–2022 (USD Million)
Table 140 Latin America: Eclinical Solutions Market Size, By Clinical Trial Phase,2015–2022 (USD Million)
Table 141 Latin America: Eclinical Solutions Market Size, By End User, 2015–2022 (USD Million)
Table 142 Brazil: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 143 Brazil: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 144 Mexico: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 145 Mexico: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 146 Rola: Eclinical Solutions Market Size, By Product, 2015-2022 (USD Million)
Table 147 Rola: Eclinical Solutions Market Size, By Clinical Trial Phase,2015-2022 (USD Million)
Table 148 Middle East & Africa: Eclinical Solutions Market Size, By Product,2015–2022 (USD Million)
Table 149 Middle East & Africa: Eclinical Solutions Market Size, By Delivery Mode, 2015–2022 (USD Million)
Table 150 Middle East & Africa: Eclinical Solutions Market Size, By Clinical Trial Phase, 2015–2022 (USD Million)
Table 151 Middle East & Africa: Eclinical Solutions Market Size, By End User,2015–2022 (USD Million)
Table 152 Agreements, Partnerships, and Collaborations (2016-2019)
Table 153 Product Deployments (2016-2019)
Table 154 Product Launches & Product Enhancements (2016-2019)
Table 155 Mergers & Acquisitions (2016-2019)
Table 156 Expansions (2016-2019)

List of Figures (40 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Eclinical Solutions Market: End-User Analysis Approach
Figure 4 Eclinical Solutions Market: Bottom-Up Approach
Figure 5 Eclinical Solutions Market: Top-Down Approach
Figure 6 Eclinical Solutions Market: Data Triangulation
Figure 7 Global Eclinical Solutions Market Size, By Product,2017 Vs. 2022 (Usd Million)
Figure 8 Global Eclinical Solutions Market Size, By Delivery Mode,2017 Vs. 2022 (USD Million)
Figure 9 Global Eclinical Solutions Market Size, By Clinical Trial Phase,2017 Vs. 2022 (USD Million)
Figure 10 Global Eclinical Solutions Market Size, By End User,2017 Vs. 2022 (USD Million)
Figure 11 Global Eclinical Solutions Market Size, By Region, 2016 (USD Million)
Figure 12 Emerging Countries Offer High Growth Opportunities During The Forecast Period
Figure 13 Edc & Cdms Segment To Dominate The Global Eclinical Solutions Market In 2022
Figure 14 Web-Hosted Delivery Mode Dominated The Eclinical Solutions Market Across All Regional Segments In 2016
Figure 15 Phase Iii Clinical Trials To Dominate The Global Eclinical Solutions Market During The Forecast Period
Figure 16 Contract Research Organizations Segment In Asia-Pacific is Expected To Witness The Highest Growth Rate
Figure 17 Global Eclinical Solutions Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Edc and Cdms Segment Dominated The Global Eclinical Solutions Market In 2016
Figure 19 North America is Estimated To Be The Largest Geographic Segment for Edc and Cdms Solutions Market In 2017
Figure 20 Asia-Pacific Projected To Be The Fastest-Growing Geographic Segment for Ctms Market During 2017-2022
Figure 21 North America is Estimated To Be The Largest Geographic Segment for Clinical Analytics Platforms Market In 2017
Figure 22 Asia-Pacific is Projected To Be The Fastest-Growing Geographic Segment for Rtsm Solutions Market Till 2022
Figure 23 Web-Hosted Solutions To Dominate The Global Eclinical Solutions Market In 2016
Figure 24 Phase Iii Trials To Witness Highest Demand Growth for Eclinical Solutions During The Forecast Period
Figure 25 Global Eclinical Solutions Market Share, By End User (2016)
Figure 26 R&D Expenditure of Top 8 Pharmaceutical Companies,2013 Vs. 2015 (USD Million)
Figure 27 Global Eclinical Solutions Market Size, By Region,2017 Vs. 2022 (USD Million)
Figure 28 North America: Eclinical Solutions Market Snapshot
Figure 29 Europe: Eclinical Solutions Market Snapshot
Figure 30 Europe: Pharmaceutical R&D Expenditure, By Country (2012)
Figure 31 Asia-Pacific: Eclinical Solutions Market Snapshot
Figure 32 Row: Eclinical Solutions Market Snapshot
Figure 33 Global Eclinical Solutions Market Share, By Key Player, 2016
Figure 34 Geographic Revenue Mix of The Leading Market Players (2015)
Figure 35 Oracle Corporation: Company Snapshot (2016)
Figure 36 Medidata Solutions, Inc.: Company Snapshot (2015)
Figure 37 Parexel International Corporation: Company Snapshot (2016)
Figure 38 Datatrak International, Inc.: Company Snapshot (2015)
Figure 39 Merge Healthcare Incorporated: Company Snapshot (2014)
Figure 40 Omnicomm Systems, Inc.: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
HIT 2208
Published ON
Apr, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the eClinical Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home